Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated With Rituximab Plus Infusional EPOCH (AMC-034 Trial)
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-0466
Full Text
Open PDFAbstract
Available in full text
Date
September 17, 2015
Authors
Publisher
American Association for Cancer Research (AACR)